Yoshiaki Morita1, Naoaki Yamada1, Teruo Noguchi2, Yoshiaki Watanabe1, Tatsuya Nishii1, Atsushi Kono1, and Tetsuya Fukuda1
1Department of Radiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan, 2Division of Cardiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan
Synopsis
Myocardial
T1 mapping has recently been applied to the quantification of extracellular
volume fraction (ECV) and has shown potential for the detection of
myocardial fibrosis. However,
for the measurement of ECV, additional scans of pre- and post-contrast T1
mapping are necessary, and the post-processing procedure is time consuming. In
this study, the myocardium-to-lumen signal ratio (M/L) in conventional late
gadolinium enhancement images with fixed inversion time showed acceptable
levels of correlation with ECV obtained by the
T1 mapping in non-ischemic cardiomyopathy, suggesting that M/L has the potential to allow for simple
quantification of the fibrotic change in non-ischemic cardiomyopathies.
Introduction
Late gadolinium enhancement (LGE) is a widely-used method
for evaluating the myocardial fibrosis in various cardiomyopathies. LGE relies
on the difference in signal intensity between fibrotic and unaffected
myocardium as a “nulled” reference, which limits its usefulness in the diagnosis
of diffuse interstitial fibrosis. Recently, myocardial T1 mapping has been
applied to the quantification of extracellular volume fraction (ECV) and has
shown potential for providing a better characterization of myocardial tissue
composition. 1 However, for measurement of ECV, additional scans of
pre- and post-contrast T1 mapping are necessary, and the post-processing
procedure is time consuming.Purpose
In this study, we evaluated the utility of simple
quantification using the myocardium-to-lumen signal ratio for assessment of
myocardial fibrosis in patients with non-ischemic cardiomyopathy and compared it
with ECVs obtained via T1 mapping.Methods
Twenty-two patients with non-ischemic
cardiomyopathies (DCM and HCM) and eight patients with normal myocardium underwent
gadolinium-enhanced cardiac MRI via a 3T clinical machine (MAGNETOM Verio,
Siemens AG Healthcare Sector, Erlangen, Germany).
LGE was performed with IR True-FISP (fixed
inversion time = 350 msec) at 2, 5, 10, and 20 minutes post-gadolinium
administration. We measured the mean signal intensity ratio of the myocardium to
lumen close to each myocardium (M/L) into 8 segments (basal and mid-ventricular,
Figure 1) using 20-minute delayed images as an index for contrast
enhancement. 2
In patients with
non-ischemic cardiomyopathies, the presence or absence of LGE was
decided visually via 20-minute delayed images. T1 mapping using Fast-MOLLI was performed on a short-axial
slice at the same level both pre-contrast as well as 21 minutes post-contrast.
Fast-MOLLI was implemented as a two-inversion recovery (IR) sequence with the
first of three and the second of five consecutive image acquisitions,
decreasing the acquisition time by approximately one-third as compared to the
original-MOLLI method. 3 The T1 map was reconstructed using eight source images
with different inversion times. The ECV was quantified according to the
following formula: ECV=λ x (1 – hematocrit),
where λ=⊿R1myocardium
/⊿R1bloodpool (⊿R1: the change of R1(=1/T1) between pre- and
post-contrast). The pre- and post-contrast T1 map was
used for automatic reconstruction of the ECV map with dedicated software (MapMaker prototype®, Medis, Leiden, Netherlands) (Figure 2). The ECV map was also divided
into eight segments. Segment-based ECV values were
measured, and the mean of the eight segmental values was calculated.Results
Figure 3 shows
the mean M/L of the normal myocardium, all patients with non-ischemic cardiomyopathies,
and LGE-positive and LGE-negative patients.
LGE-negative
patients showed higher M/Ls than what were seen in a normal myocardium
(p<0.01).
The
M/L was significantly correlated with the ECV obtained by the T1 map (r = 0.66,
p<0.0001, Figure 4).
The
cut-off value for M/L to differentiate between a normal myocardium and non-ischemic cardiomyopathies
was 0.42 (specificity 84%, sensitivity 82%, area under the curve 0.89, Figure 5).Discussion
The
results of this study demonstrated that the M/L shows acceptable levels of
correlation with the T1 mapping-derived ECV, which is proportional to tissue
concentration of gadolinium and effective for quantifying tissue enhancement. Our
study revealed a strong linear relationship between the T1-map-based ECV and
histological fibrosis by endomyocardial biopsy, which is an important finding because
it indicates that ECV is suitable for stratifying patients based on their
myocardial fibrosis volume fraction. 4
From
these findings, M/L allows the detection of fibrotic change in non-ischemic cardiomyopathies via
conventional LGE images with fixed inversion times. Furthermore, myocardium that
appeared to be unenhanced in the LGE images showed a higher M/L than normal
myocardium, suggesting that M/L could detect diffuse fibrotic changes that are difficult
to assess visually with only conventional LGE. Future work will focus on
putting this simple quantification using M/L into practical use such as for differentiation
from other myocardial diseases, monitoring of therapeutic effects, and for prognostic
information. Conclusion
Our results suggested that the myocardium-to-lumen signal ratio has the potential to allow for simple quantification of fibrotic
changes in non-ischemic cardiomyopathies without additional scans and
post-processing. Acknowledgements
No acknowledgement found.References
1.
Ugander M et al. Extracellular volume
imaging by magnetic resonance imaging provides insights into overt and
sub-clinical myocardial pathology. Eur Heart J. 2012;33(10):1268-78.
2. Kono AK et al. Dynamic late gadolinium enhancement
simply quantified using myocardium to lumen signal ratio: Normal range of ratio
and diffuse abnormal enhancement of cardiac amyloidosis. J Magn Reson Imaging.
2011 Jul;34(1):50-5.
3. Morita Y et al. Validation of a Faster Modified
Look-Locker Inversion-recovery (MOLLI) method for myocardial T1 mapping on 3T
MRI. ISMRM 20th Scientific Meeting and Exhibition 2012.
4.
Morita Y et al. Myocardial extracellular volume fraction (ECV) quantified by T1
mapping can detect diffuse myocardial fibrosis in dilated cardiomyopathy (DCM):
Comparison with histological collagen volume fraction by endomyocardial biopsy
(EMB). ISMRM 24th Scientific Meeting and Exhibition 2016.